Atabak Mokari Insider Trades & Stock Holdings

Chief Financial Officer · Corcept Therapeutics Incorporated · Latest filing Jun 15, 2026

Atabak Mokari, Chief Financial Officer at Corcept Therapeutics Incorporated has 2 Form 4 trades on file since Jun 15, 2026. Open-market activity: 0 purchases ($0) and 1 sale ($3.25M), net -$3.25M. Latest filing: disposed of 40K shares of $CORT on Jun 15, 2026 at $81.15.

Trades on file

2

Open-market bought

$0

Open-market sold

$3.25M

Net open-market

-$3.25M

Latest filing

Jun 15, 2026

All insider trades by Atabak Mokari

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 15, 2026	$CORT	Sell (Open-market sale) 10b5-1	40K	$81.15	$3.25M			-4.1%	+7.8%		Chief Financial Officer		—
Jun 15, 2026	$CORT	Buy (Option exercise)	40K	$19.26	$770.40K			-4.1%	+7.8%		Chief Financial Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Atabak Mokari traded

• $CORT

Frequently asked questions

Has Atabak Mokari been buying or selling stock?

Atabak Mokari has 0 open-market purchases and 1 open-market sale on file, net -$3.25M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Atabak Mokari's latest insider trade?

disposed of 40K shares of $CORT on Jun 15, 2026 at $81.15.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.